ArticleIrish journal of medical science2026
Active radiologist role in contrast administration during MRI follow-up of soft tissue sarcoma reduces gadolinium usage: a cost-saving analysis study.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSoft tissue sarcoma (STS) surveillance relies on frequent MRI, often using gadolinium-based contrast agents (GBCAs) without clear guidelines. While GBCAs enhance detection, they increase costs and potential long-term risks from gadolinium deposition.
aimsThis study evaluated whether real-time radiologist assessment during MRI could reduce unnecessary GBCA use while maintaining diagnostic accuracy in STS follow-up, analysing cost savings and clinical outcomes.
methodsA retrospective audit reviewed 178 MRI scans (Jan 2023–Jan 2024) from 143 STS patients. Senior musculoskeletal radiologists determined contrast necessity after reviewing non-contrast sequences. Cost analysis used Time-Driven Activity-Based Costing (TDABC).
resultsContrast usage decreased from 100% to 70%, avoiding GBCA in 30% (54/178) of scans. Patients > 5 years post-diagnosis saw a 74% reduction in contrast use. Annual savings totalled €2,184.84 (€40.46 per contrast scan avoided), with 20 min saved per non-contrast scan.
conclusionsActive radiologist involvement in STS MRI follow-up safely reduces gadolinium use without compromising recurrence detection. This approach lowers costs, optimizes scanner efficiency, and minimizes patient exposure to potential gadolinium-related risks.
Indexed as
Identifiers
41351809What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.